88IV - PR Newswire Asia's news - Medical/Pharmaceuticals


Accro Bioscience Announces First Patient Dosed in Phase IIb Study of AC-101 in Moderate-to-Severe Ulcerative Colitis NEW YORK and SUZHOU, China , Sept. 20, 2026 /PRNewswire/ -- Accro Bioscience Inc. (Accro Bio), a clinical-stage biotechnology company pioneering the development of novel therapeutics for immune mediated ... 2026-09-20T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Ping An Good Doctor Launches " Ping An GlobalCare": AI-Powered Multilingual Services Break Down Healthcare Barriers for Expats in China HONG KONG , Sept. 20, 2026 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor" or the "Company"; Stock Code: 1833.HK) recently unveiled its ... 2026-09-20T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
BioShanghai Week 2026 Opens -- Joining Forces to Build a Global Biopharmaceutical Innovation Ecosystem SHANGHAI , Sept. 20, 2026 /PRNewswire/ -- A news report from Yicai Global: ... 2026-09-20T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Fosun Health Hosts First International Oncology Treatment Forum in Foshan; International Oncology Alliance Officially Established FOSHAN, China , Sept. 20, 2026 /PRNewswire/ -- The first International Oncology Treatment Forum, hosted by Fosun Health, was held in Foshan, Guangdong Province, China. Oncology experts from multiple ... 2026-09-20T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
HONG KONG RADIOLOGIST ADVOCATES HUMAN-CENTRED AI AT UN HUMAN RIGHTS COUNCIL IN GENEVA Dr. Kevin Lau Chung-hang welcomes deepening Medical AI: AI for Diagnostic Precision, Doctors for Compassionate Care ... 2026-09-19T Computer/Electronics Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
NAVER D2SF Invests in AI-Driven Precision Medicine Company ImpriMed ImpriMed combines ex vivo functional testing with multimodal AI to support personalized cancer treatment decisions and drug development The investment is part of ImpriMed's $10 million Series A2 bridge ... 2026-09-18T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Jiahui Health Highlights China's Growing Role in Global Medical Tourism at WTO Public Forum 2026 GENEVA , Sept. 18, 2026 /PRNewswire/ -- China is seeing growing momentum in inbound medical tourism, driven by expanding access to innovative therapies, visa facilitation and the development of internationally ... 2026-09-18T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
2026 Tang Prize Award Ceremony Honors Six Laureates Outstanding Achievements for Global Well-Being and Our Shared Future ... 2026-09-18T Biotechnology Health Care/Hospital Higher Education Medical/Pharmaceuticals
Rosti Group highlights cutting-edge medical solutions at Medical Fair Asia 2026 SINGAPORE , Sept. 18, 2026 /PRNewswire/ -- A report from Ringiertrade . ... 2026-09-18T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals Trade show news
Datasea's AI Agent Digital Marketing Services Enter Scaled Commercial Deployment, with Five Agreements Representing Potential Annualized Service Volume of Up to Approximately US$89.4 Million (RMB600 Million) Five-customer AI agent services advance into actual delivery; CEO reiterates long-term confidence through a previously disclosed US$1.0 million Rule 10b5-1 share purchase plan ... 2026-09-17T Computer Software Computer/Electronics Internet Technology Medical/Pharmaceuticals

PR Newswire Asia's news > Medical/Pharmaceuticals